Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-16 | Mr. Kummeth has served as a director of the Company since 2018. He has served as the President and Chief Executive Officer and a director of Bio-Techne Corporation (Nasdaq: TECH) since 2013. Prior to joining Bio-Techne, Mr. Kummeth served as President of Mass Spectrometry and Chromatography at Thermo Fisher Scientific Inc. and was President of the Laboratory Consumables Division from 2009 to September 2011. Prior to joining Thermo Fisher, he served in various roles during his 24-year career at 3M Corporation, most recently as the Vice President of the company's Medical Division from 2006 to 2008. Mr. Kummeth served as a director of Sparton Corporation (NYSE: SPA) from 2011 to 2019, where he was most recently a member of the Compensation Committee. Mr. Kummeth received a Master of Science in Computer Science from the University of St. Thomas and a Master of Business Administration from the Carlson School of Business at the University of Minnesota. He is a graduate of the University of North Dakota, where he received a Bachelor of Science in Electrical Engineering. Director Qualifications Mr. Kummeth’s significant experience in the medical industry will be important to our business as we seek to grow our medical business and introduce new medical products to the market. In addition, his leadership experience, including as President and Chief Executive Officer of a public company and as a director of multiple public companies, provides the Board with an important perspective on many topics, including governance, shareholder engagement and risk management. |
| 2020-04-21 | Charles Kummeth Age: 59 Director Since: 2018 Committee Memberships: > Audit > Mergers and Acquisitions > Nominating > Technology 2019 DIRECTOR COMPENSATION TABLE Charles Kummeth Fees Earned or Paid in Cash: 86,000 Stock Awards: 99,998 Total: 185,998 |
| 2021-04-07 | Charles Kummeth 60 Director Since: 2018 Committee Memberships: Compensation, Mergers and Acquisitions (Chair), Technology 2020 DIRECTOR COMPENSATION TABLE Charles Kummeth Stock Awards ($): 177,027 Total ($): 177,027 |
| 2022-04-21 | Charles Kummeth Age: 61 Director Since: 2018 Committee Memberships: > Compensation > Mergers and Acquisitions (Chair) > Technology 2021 DIRECTOR COMPENSATION TABLE Charles Kummeth Fees Earned or Paid in Cash ($) 96,000 Stock Awards ($) 100,009 Total ($) 196,009 |
| 2023-04-06 | Charles Kummeth 62 Director Since 2018 Committees: Compensation, M&A (Chair), Technology President and CEO of Bio-Techne Corporation |
| 2024-04-04 | The table below sets forth the compensation of each non-employee director in 2023. Charles Kummeth 116,000 fees earned in cash, 125,000 stock awards, total 241,000. |
| 2025-03-27 | Charles Kummeth Age: 64 3 Director Since: 2018 3 Independent Committee(s): 3 Compensation and Talent 3 Mergers and Acquisitions (Chair) 3 Technology Mr. Kummeths significant experience in the medical industry is important to our business as we seek to grow our medical business and introduce new medical products to the market. In addition, his leadership experience, including as President and Chief Executive Officer of a public company and as a director of multiple public companies, provides the Board with an important perspective on many topics, including governance, shareholder engagement and risk management. 2024 Director Compensation Table The table below sets forth the compensation of each non-employee director in 2024. Charles Kummeth 116,000 135,017 251,017 |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22